Symptomatic Treatment of Common Cold Symptoms

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

A two-arm, multicenter, randomized, double-blind, single dose placebo-controlled parallel groups study evaluating efficacy and tolerability of 800 mg Acetylsalicylic Acid (Aspirina C) in adult patients with a common cold during a two hour in patient phase; and a follow-up period of five days of home treatment as required.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Aspirin

Criteria

Inclusion Criteria:

• Age between 18 and 65 years

• Onset of cold symptoms within 48 hours before screening

• Objective symptoms of common cold

• Subjective symptoms of common cold

Exclusion Criteria:

• Pregnancy or lactation period

• Active peptic ulcer

• Hemorrhagic diathesis

• History of chronic or recurrent ulcer disease or history of gastro-intestinal bleeding

• Hypersensitivity to acetylsalicylic acid, to paracetamol, to any other component of the study medication, to anti-inflammatory or antirheumatic drugs, to other allergens